Novartis and MMV expand partnership to develop KAF156
15 June 2016 | By Victoria White, Digital Content Producer
Novartis' KAF156 is one of the first antimalarial drug candidates to enter Phase IIb clinical development in more than 20 years...
List view / Grid view
News
Jardiance reduces risk of progressive kidney disease in type 2 diabetes
14 June 2016 | By Victoria White, Digital Content Producer
Jardiance reduced the risk for new-onset or worsening kidney disease by 39% versus placebo in adults with type 2 diabetes with established CV disease...
Shire to license global rights for PF-00547659 from Pfizer
14 June 2016 | By Victoria White, Digital Content Producer
PF-00547659 is an investigational biologic being evaluated for the treatment of moderate-to-severe inflammatory bowel disease (IBD)...
Tecentriq to dominate the bladder cancer market, says GlobalData
14 June 2016 | By Victoria White, Digital Content Producer
The launch of Roche’s Tecentriq will usher in a dramatic change in the treatment paradigm of bladder cancer, according to an analyst with GlobalData...
Ertugliflozin shows significant A1C reductions in type 2 diabetes
14 June 2016 | By Victoria White, Digital Content Producer
Two studies of ertugliflozin, an investigational oral SGLT-2 inhibitor for the treatment of patients with type 2 diabetes, met their primary endpoints...
Clinical trial to test promising new treatment for chronic cough
14 June 2016 | By Victoria White, Digital Content Producer
If approved, AF-219 would be the first new cough drug in 50 years and offer hope to the millions of people living with chronic cough...
MK-1293 shows non-inferiority to Lantus in two Phase III studies
14 June 2016 | By Victoria White, Digital Content Producer
Merck has announced results from two Phase III studies evaluating MK-1293 for the treatment of people with type 1 and type 2 diabetes...
Gang sentenced for illegal importation and sale of drugs in the UK
14 June 2016 | By Victoria White, Digital Content Producer
The gang imported over 1.2 million unlicensed erectile dysfunction tablets and over 141,000 other illegal medicines including diazepam worth over £3.5 million...
Yusen Logistics makes major investments at Duisburg-Rheinhausen site
Yusen Logistics has significantly strengthened its logistics presence in Duisburg; acquiring a new warehouse and expanding its storage capacity by 8,700 m². The total storage capacity of the multi-warehouse site is now 62,000 m².
Final results from the INO-VATE ALL study of inotuzumab ozogamicin
13 June 2016 | By Victoria White, Digital Content Producer
Results showed improvement over chemotherapy on a number of measures including complete haematologic remission and progression-free survival...
Amgen presents new data for Kyprolis in multiple myeloma at EHA
13 June 2016 | By Victoria White, Digital Content Producer
A post-hoc analysis of the Phase III ASPIRE study highlighted the benefit of continued treatment with Kyprolis, lenalidomide and dexamethasone (KRd)...
Jardiance data shows reduced risk of CV death in type 2 diabetes
13 June 2016 | By Victoria White, Digital Content Producer
New data for Jardiance (empagliflozin) show that reduced risk for cardiovascular (CV) death was consistent across age groups in adults with type 2 diabetes...
LixiLan-O and LixiLan-L meet primary endpoints
Results from Sanofi’s Phase III LixiLan-O and LixiLan-L clinical trials have been presented at the American Diabetes Association 76th Scientific Sessions.
Researchers develop first vaccine against toxic shock syndrome
13 June 2016 | By Victoria White, Digital Content Producer
Researchers have developed the world's first safe and effective vaccine against toxic shock syndrome and successfully tested it in a Phase I trial...
New data for Trulicity and Tradjenta in type 2 diabetes
Lilly has announced new findings from separate studies of Trulicity (dulaglutide) and Tradjenta (linagliptin) at the American Diabetes Association 76th Scientific Sessions.
